Lincoln Park Capital Fund is a Chicago-based asset management firm focused on opportunistic investing in public and private companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
Marker Therapeutics
|
Post-IPO Equity | $25M | Biotechnology | Yes |
Mar 7, 2022
Biodesix
|
Post-IPO Equity | $50M | Biotechnology | Yes |
Mar 19, 2021
X4 Pharmaceuticals
|
Post-IPO Equity | $55M | Biotechnology | — |